Neuroradiologic Correlates of Cognitive Impairment in Adult Moyamoya Disease

References

1. 1.↵
   1. Suzuki J,
   2. Takaku A

   . Cerebrovascular “Moyamoya” disease: disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288–99

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Miyamoto S,
   2. Kikuchi H,
   3. Karasawa J,
   4. et al

   . Study of the posterior circulation in Moyamoya disease: clinical and neuroradiological evaluation. J Neurosurg 1984;61:1032–37

   PubMedWeb of Science
3. 3.↵
   1. Mineharu Y,
   2. Liu W,
   3. Inoue K,
   4. et al

   . Autosomal dominant Moyamoya disease maps to chromosome 17q25.3. Neurology 2008;70:2357–63. Epub 2008 May 7

   Abstract/FREE Full Text
4. 4.↵
   1. Yamauchi T,
   2. Tada M,
   3. Houkin K,
   4. et al

   . Linkage of familial Moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000;31:930–35

   Abstract/FREE Full Text
5. 5.↵
   1. Suzuki J,
   2. Kodama N

   . Moyamoya disease–a review. Stroke 1983;14:104–09

   Abstract/FREE Full Text
6. 6.↵
   1. Matsushima Y,
   2. Aoyagi M,
   3. Masaoka H,
   4. et al

   . Mental outcome following encephaloduroarteriosynangiosis in children with Moyamoya disease with the onset earlier than 5 years of age. Childs Nerv Syst 1990;6:440–43

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Sato H,
   2. Sato N,
   3. Tamaki N,
   4. et al

   . Chronic low-perfusion state in children with Moyamoya disease following revascularization. Childs Nerv Syst 1990;6:166–71

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Karzmark P,
   2. Zeifert PD,
   3. Tan S,
   4. et al

   . Effect of Moyamoya disease on neuropsychological functioning in adults. Neurosurgery 2008;62:1048–51, discussion 1051–52

   CrossRefPubMed
9. 9.↵
   1. Vagal AS,
   2. Leach JL,
   3. Fernandez-Ulloa M,
   4. et al

   . The acetazolamide challenge: techniques and applications in the evaluation of chronic cerebral ischemia. AJNR Am J Neuroradiol 2009;30:876–84. Epub 2009 Feb 26

   Abstract/FREE Full Text
10. 10.↵
    1. Kim JM,
    2. Lee SH,
    3. Roh JK

    . Changing ischaemic lesion patterns in adult Moyamoya disease. J Neurol Neurosurg Psychiatry 2009;80:36–40

    Abstract/FREE Full Text
11. 11.↵
    1. Jefferson AL,
    2. Glosser G,
    3. Detre JA,
    4. et al

    . Neuropsychological and perfusion MR imaging correlates of revascularization in a case of Moyamoya syndrome. AJNR Am J Neuroradiol 2006;27:98–100

    Abstract/FREE Full Text
12. 12.↵
    1. Rim NJ,
    2. Kim HS,
    3. Shin YS,
    4. et al

    . Which CT perfusion parameter best reflects cerebrovascular reserve? Correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in Moyamoya patients. AJNR Am J Neuroradiol 2008;29:1658–63

    Abstract/FREE Full Text
13. 13.↵
    1. Kuroda S,
    2. Houkin K,
    3. Kamiyama H,
    4. et al

    . Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001;32:2110–16

    Abstract/FREE Full Text
14. 14.↵
    1. Ogasawara K,
    2. Ogawa A,
    3. Yoshimoto T

    . Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke 2002;33:1857–62

    Abstract/FREE Full Text
15. 15.↵
    1. Lee M,
    2. Zaharchuk G,
    3. Guzman R,
    4. et al

    . Quantitative hemodynamic studies in Moyamoya disease: a review. Neurosurg Focus 2009;26:E5

    PubMed
16. 16.↵
    1. Ikezaki K,
    2. Matsushima T,
    3. Kuwabara Y,
    4. et al

    . Cerebral circulation and oxygen metabolism in childhood Moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 1994;81:843–50

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Touho H,
    2. Karasawa J,
    3. Ohnishi H

    . Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease. Stroke 1996;27:282–89

    Abstract/FREE Full Text